BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung cancer
,
Stem cell
,
Metabolism of nitric oxide
,
Prozac
,
rs7903146
,
PBX1
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ribonucleoside
Summary
General Info
Curated Studies
Most Correlated Studies
Cisplatin toxicity in MCF-7 breast adenocarcinoma cell line - expression changes with time
S. cerevisiae segregants and parental strains during wine fermentation
S.cerevisiae during transition from fermentative to glycerol-based respiratory growth
Skin fibroblasts of patients with defective complex I (CI) oxidative phosphorylation disease
Breast tumors with pathologic complete response (pCR) or residual disease (RD) upon chemotherapy
Explore Curated Studies Results
Literature
Most Relevant Literature
Regioselective 2'-Silylation of Purine Ribonucleosides for Phosphoramidite RNA Synthesis.
Synthesis of Azido and Triazolyl Purine Ribonucleosides.
Ribonucleosides from tRNA in hyperglycemic mammalian cells and diabetic murine cardiac models.
Interrogating the transcriptome with metabolically incorporated ribonucleosides.
Synthesis of Enantiomerically Pure Pyrimidine Ribonucleosides Locked in the South Conformation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochl…
A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ